Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications.

Yu-Ming ChengChia-Chi WangJia-Horng Kao

Published in: Hepatology international (2022)

The grand, population-based study showed MAFLD with new diagnostic criteria to aid in identifying a greater number of high-risk patients of metabolic, liver, and cardiovascular complications, suggesting MAFLD may be a better nomenclature than NAFLD in clinical practice.

Keyphrases

end stage renal disease
clinical practice
chronic kidney disease
newly diagnosed
risk factors
peritoneal dialysis
prognostic factors
patient reported